Health
Researchers develop promising new drug candidates to treat ALS – Drug Target Review
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Posted: 2 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Scientists report that they have taken a significant step forward in the search to find effective new drugs for the treatment of Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease.
Researchers from the University of Liverpool, UK, and University of Nagoya, Ja…
-
General15 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News19 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News19 hours agoWest End icon closes doors
-
General21 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay